1921
Volume 82, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Liver fibrosis (LF) must be assessed before talking treatment decisions in hepatitis B. In Burkina Faso, liver biopsy (LB) remains the “gold standard” method for this purpose. Access to treatment might be simpler if reliable alternative techniques for LF evaluation were available. The hepatitis B virus (HBV)-infected patients who underwent LB was invited to have liver stiffness measurement (Fibroscan) and serum marker assays. Fifty-nine patients were enrolled. The performance of each technique for distinguishing F0F1 from F2F3F4 was compared. The area under receiver operating characteristic (AUROC) curves was 0.61, 0.71, 0.79, 0.82, and 0.87 for the aspartate transaminase to platelet ratio index (APRI), Fib-4, Fibrotest, Fibrometre, and Fibroscan. Elastometric thresholds were identified for significant fibrosis and cirrhosis. Combined use of Fibroscan and a serum marker could avoid 80% of biopsies. This study shows that the results of alternative methods concord with those of histology in HBV-infected patients in Burkina Faso. These alternative techniques could help physicians to identify patients requiring treatment.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2010.09-0088
2010-03-01
2017-09-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/82/3/454.html?itemId=/content/journals/10.4269/ajtmh.2010.09-0088&mimeType=html&fmt=ahah

References

  1. Collenberg E, Ouedraogo T, Ganamé J, Fickenscher H, Kynast-Wolf G, Becher H, Kouyaté B, Kräusslich HG, Sangaré L, Tebit DM, , 2006. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: a comparative analysis. J Med Virol 78: 683692.[Crossref]
  2. Cadranel JF, Rufat P, Degos F, , 2000. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 32: 477481.[Crossref]
  3. ter Borg F, ten Kate JJ, Cuypers HT, Leentvaar-Kuijpers A, Oosting J Wertheim-van Dillen PM, Honkoop P, Rasch MC, de Man RA, van Hattum J, Chamuleau RA, Tytgat GN, Jones EA, , 2000. A survey of liver pathology in needle biopsies from HbsAg and anti-Hbe positive individuals. J Clin Pathol 53: 541548.[Crossref]
  4. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, de Lédinghen V, Marcellin P, Dhumeux D, Trinchet JC, Beaugrand M, , 2005. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41: 4854.[Crossref]
  5. Ganne-Carrié N, Ziol M, deLedinghen V, Douvin C, Marcellin P, Castera L, Dhumeux D, Trinchet JC, Beaugrand M, , 2006. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 44: 15111517.[Crossref]
  6. Imbert-Bismuth F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T, , 2001. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection. Lancet 357: 10691075.[Crossref]
  7. Calès P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konaté A, Gallois Y, Ternisien C, Chevailler A, Lunel F, , 2005. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 42: 13731381.[Crossref]
  8. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS, , 2003. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C . Hepatology 38: 518526.[Crossref]
  9. Vallet-Pichard A, Mallet V, Pol S, , 2006. FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients. Hepatology 44: 769.[Crossref]
  10. 1994. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20: 1520.[Crossref]
  11. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Lédinghen V, , 2005. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128: 343350.[Crossref]
  12. Hui CK, Leung N, Shek TWH, Yao H, Lee WK, Lai JY, Lai ST, Wong WM, Lai LS, Poon RT, Lo CM, Fan ST, Lau GK, , Hong Kong Liver Fibrosis Study Group, 2007. Sustained disease remission after spontaneous HbeAg seroconversion is associtaed with reduction in fibrosis progression in chronic hepatits B Chinese patients. Hepatology 46: 690698.[Crossref]
  13. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Ledinghen V, Beaugrand M, , 2008. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 9: 242247.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2010.09-0088
Loading
/content/journals/10.4269/ajtmh.2010.09-0088
Loading

Data & Media loading...

  • Received : 15 Feb 2009
  • Accepted : 16 Nov 2009

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error